Etiology and complications of thrombocytopenia in hospitalized medical patients Eric M. FountainGowthami M. Arepally OriginalPaper 04 January 2017 Pages: 429 - 436
Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system Kevin P. BlidenRahul ChaudharyPaul A. Gurbel OriginalPaper 28 February 2017 Pages: 437 - 445
Association between CK-MB Area Under the Curve and Tranexamic Acid Utilization in Patients Undergoing Coronary Artery Bypass Surgery Sean van DiepenPeter D. MerrillRenato D. Lopes OriginalPaper 14 February 2017 Pages: 446 - 453
Implications of an inpatient warfarin dosing nomogram on safety outcomes post-discharge Nibal ChamounC. Gabriela MacíasMaichi T. Tran OriginalPaper 15 December 2016 Pages: 454 - 462
Evaluating the safety and effectiveness of venous thromboembolism prophylaxis in patients with sickle cell disease Denise KelleyLauren Thornton JonesNicole Bohm OriginalPaper 10 December 2016 Pages: 463 - 468
Family history of venous thromboembolism and mortality after venous thromboembolism: a Swedish population-based cohort study Bengt ZöllerMirnabi PirouzifardKristina Sundquist OriginalPaper Open access 19 December 2016 Pages: 469 - 475
Evaluation of safety and effectiveness of standardized antifactor Xa-based unfractionated heparin protocols in obese versus non-obese patients Manuel IsherwoodMichelle L. MurphyJames M. Hollands OriginalPaper 09 January 2017 Pages: 476 - 483
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER®, RE-COVER™ II, and RE-MEDY™ Martin FeuringSam SchulmanSamuel Z. Goldhaber OriginalPaper Open access 16 February 2017 Pages: 484 - 489
Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation B. SteppichF. DoblerI. Ott OriginalPaper 18 March 2017 Pages: 490 - 497
Prospective evaluation of a bivalirudin to warfarin transition nomogram Benjamin HohlfelderKatelyn W. SylvesterJean M. Connors OriginalPaper 19 January 2017 Pages: 498 - 504
Appropriateness of direct oral anticoagulant dosing for venous thromboembolism treatment Emmeline TranAshley DuckettNicole Bohm OriginalPaper 07 March 2017 Pages: 505 - 513
Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study Simon ManthaYimei MiaoGerald A. Soff OriginalPaper Open access 16 February 2017 Pages: 514 - 518
Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review Homam IbrahimSunil V. Rao ReviewPaper 22 February 2017 Pages: 519 - 527
Intravenous thrombolysis for stroke after Dabigatran reversal with Idarucizumab: an update Manuel CappellariStefano ForlivesiPaolo Bovi Letter to the Editor 18 February 2017 Pages: 528 - 529
Decompressive surgery in malignant cerebral venous sinus thrombosis: what predicts its outcome? Rohan MahaleAnish MehtaRangasetty Srinivasa OriginalPaper 16 March 2017 Pages: 530 - 539
Diabetes mellitus is associated with increased bleeding in pulmonary embolism receiving conventional anticoagulant therapy: findings from a “real-world” study Zhu ZhangZhenguo ZhaiChen Wang OriginalPaper 16 January 2017 Pages: 540 - 549
Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial Alma Rut OskarsdóttirBrynja R. GudmundsdottirPall T. Onundarson OriginalPaper 18 February 2017 Pages: 550 - 561
Effects of thromboprophylactic doses of apixaban and rivaroxaban on coagulation and thrombin generation in association with total hip replacement Tuukka A. HelinLauri VirtanenRiitta Lassila OriginalPaper 17 March 2017 Pages: 562 - 569
